Thank you, We are trying to figure out as it seems most dermatologists don’t know if a pde4 or IL-17 or a IL-23 inhibitor is best with pc as he also has mutations, so we are researching what is best between these
It’s interesting about PSA rise on PDE4 inhibitor Otezla. Clearly stay away from that. An IL-17 inhibitor sounds like it is worth a try as long as you follow PSA response. I have been wondering if these drugs could actually be beneficial in PC by strongly lowering inflammation? (I do not have psoriasis, thankfully) Paul
That is indeed the question: which, if any, inflammatory and immune modulators might be of benefit without undue risk of excessive (severe) immune repression? As inflammation is also a key driver of cancer progression. (I do not have psoriasis or other autoimmune disease.)
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.